This invention provides compounds of formula I, having the structure
##STR1##
wherein R1, R2, R3, R4, A, and
B are as defined in the specification, or a pharmaceutically acceptable salt thereof,
that are useful in treating metabolic disorders mediated by insulin resistance
or hyperglycemia.
